Combined PET/CT Imaging in Oncology Impact on Patient Management

This publication has 15 references indexed in Scilit:

• Staging Non-Small Cell Lung Cancer with Whole-Body PET
  Radiology, 1999
• Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
  RadioGraphics, 1999
• FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease
  Annals of Oncology, 1998
• Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
  Journal of Clinical Oncology, 1998
• Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
  Radiology, 1998
• FDG uptake, tumour characteristics and response to therapy
  Nuclear Medicine Communications, 1998
• Noninvasive determination of local cerebral metabolic rate of glucose in man
  American Journal of Physiology-Endocrinology and Metabolism, 1980
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method
  Annals of Neurology, 1979